Back

Correlation of NT-proBNP and residual ischemic risk in patients with heart failure and myocardial revascularization.

11 May 2024 (11:40 - 13:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - biomarkers 1 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mrs Janna Cazacu

Institute of Cardiology of Moldova, Chisinau (Moldova (Republic of))

5 More presentations in this session

Presentation thumbnail
Rational use of natriuretic peptide testing in primary care - an observational study from a Danish regional hospital
Doctor L. Lylloff (Herning, DK) Associate Professor N. Hornung (Herning, DK)
Abstract Slides Video
Presentation thumbnail
Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: the PARACOR-19 randomized clinical trial
Doctor S. Greene (Durham, US)
Abstract Slides Video
Presentation thumbnail
CA125 assessment using ABEI-based assay in heart failure: implications for disease severity and cardiac biomarkers
Professor D. Gruson (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
The relationship of natriuretic peptides and body mass index in chronic heart failure, a systematic review
Professor C. Ross (Belfast, GB)
Abstract Slides Video
Presentation thumbnail
QRS complex duration and type conduction disturbances as a simple predictor of left ventricle remodelation in patients with recent onset of dilated cardiomyopathy?
Professor R. Pudil (Prague, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - biomarkers 1

The Event

Event poster

Heart Failure 2024

11 May 2024 11:40 CET
You may be interested in
thumbnail
Congress Presentation
Etiologies and predictors of mortality in an all-comer population of patients with non-ischemic heart failure
thumbnail
Congress Presentation
Predictors of early left ventricular reverse remodelling and prognosis in new-onset heart failure of non-ischemic origin
thumbnail
Congress Presentation
Risk stratification guided by NT-proBNP after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources